Domov › Kolorektalni rak › Kalifornija › San Diego
Klinične študije za Kolorektalni rak v San Diego, CA
25 študij za Kolorektalni rak išče udeležence na lokacijah v San Diego in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Vključevanje udeležencev
- Jennifer Moreno Department of Veterans Affairs Medical Cneter, San Diego
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 mi stran
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- University of California San Diego Moores Cancer Center, San Diego
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Vključevanje udeležencevFaza 1/2
- Sharp Memorial Hospital, San Diego
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Vključevanje udeležencevFaza 1
- ALX Center 9, La Jolla · 11 mi stran
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 3
- UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Medical Center - Rancho Bernardo, San Diego
- in še 3
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Vključevanje udeležencevOpazovalna študija
- University of California San Diego, La Jolla · 11 mi stran
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Vključevanje udeležencevFaza 1/2
- UC San Diego Moores Cancer Center, La Jolla · 11 mi stran
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi stran
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi stran
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Vključevanje udeležencevFaza 1
- UC San Diego Moores Cancer Center, San Diego
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
Vključevanje udeležencevFaza 2
- Scripps Clinic Torrey Pines, La Jolla · 11 mi stran
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Sharp Healthcare, San Diego
- UCSD, La Jolla · 11 mi stran
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Investigative Site #101, San Diego
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Vključevanje udeležencevFaza 4
- University of California San Diego, La Jolla · 11 mi stran
Early Detection of Advanced Adenomas and Colorectal Cancer
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- University of California San Diego, San Diego
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi stran
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Vključevanje udeležencevFaza 1
- University of California San Diego Moores Cancer Center, San Diego
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
Vključevanje udeležencevOpazovalna študija
- VA San Diego Healthcare System, San Diego, CA, San Diego
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla · 11 mi stran
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi stran
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Moores Cancer Center UC San Diego Health, La Jolla · 11 mi stran
A Beta-only IL-2 ImmunoTherapY Study
Vključevanje udeležencevFaza 1/2
- Sharp Memorial Hospital, San Diego
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Vključevanje udeležencevFaza 3
- Moores Cancer Center - UCSD Health, La Jolla · 11 mi stran
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi stran
Študije za Kolorektalni rak v drugih mestih
- Houston, TX102 študij
- New York City, NY78 študij
- Nashville, TN69 študij
- Boston, MA63 študij
- Los Angeles, CA59 študij
- Arlington, VA52 študij
- St. Louis, MO50 študij
- San Antonio, TX46 študij
- Philadelphia, PA44 študij
- Grand Rapids, MI40 študij
- Baldwin Park, CA37 študij
- Chicago, IL34 študij
Druge študije v San Diego
- Nemalicelični pljučni rak48 študij
- Rak dojke41 študij
- Rak (vse vrste)32 študij
- Rak prostate31 študij
- Metastatski rak30 študij
- Rak jajčnikov24 študij
- Rak trebušne slinavke24 študij
- Rak pljuč23 študij
- Debelost23 študij
- Srčno popuščanje23 študij
- Depresija21 študij
- Melanom18 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.